Recap: Cocrystal Pharma Q4 Earnings

Cocrystal Pharma, Inc. +4.31%

Cocrystal Pharma, Inc.




Cocrystal Pharma (NASDAQ:COCP) reported its Q4 earnings results on Thursday, March 28, 2024 at 08:00 AM.

Here's what investors need to know about the announcement.


Cocrystal Pharma beat estimated earnings by 27.0%, reporting an EPS of $-0.44 versus an estimate of $-0.6.

Revenue was down $0 from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.12 which was followed by a 0.0% increase in the share price the next day.

** Listen to the earnings announcement yourself by clicking here. **

To track all earnings releases for Cocrystal Pharma visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Every question you ask will be answered
Scan the QR code to contact us
Also you can contact us via